Cardiovascular Systems Inc.
Investigation of Potential Shareholder Action Against Cardiovascular Systems Inc. (Nasdaq: CSII)
Kessler Topaz Meltzer & Check, LLP is investigating a potential class action on behalf of shareholders of Cardiovascular Systems, Inc.
About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc. is a medical technology company that develops, manufactures, and markets devices to treat vascular diseases in the United States.
Alleged Wrongful Conduct
Kessler Topaz Meltzer & Check LLP is investigating potential claims on behalf of the Company’s shareholders. Specifically, the investigation relates to Cardiovascular Systems, Inc.’s announcement that a whistleblower lawsuit was filed in 2013, alleging that it engaged in a fraudulent marketing scheme to maximize profits through illegal kickbacks, off-label promotion, and violations of federal laws and regulations.
If purchased shares of Cardiovascular Systems Inc. (Nasdaq: CSII) and would like to learn more about our investigation, please fill out our online form or contact us today at 888-299-7706 or [email protected].